New combo shot aims to simplify diabetes management
NCT ID NCT06716424
First seen Jan 22, 2026 · Last updated May 16, 2026 · Updated 15 times
Summary
This study tests a pre-mixed injection that combines two diabetes drugs (insulin glargine and lixisenatide) in adults with type 2 diabetes whose blood sugar is not well controlled by pills or other injectables. About 105 participants will receive the combo treatment to see if it safely improves blood sugar levels. The goal is to offer a simpler, more effective option for managing diabetes long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number : 3560001
Kolkata, 700020, India
-
Investigational Site Number : 3560003
Kanpur, 208002, India
-
Investigational Site Number : 3560005
Hyderabad, 500034, India
-
Investigational Site Number : 3560006
Indore, 452010, India
-
Investigational Site Number : 3560007
Delhi, 110088, India
-
Investigational Site Number : 3560008
Pune, 411004, India
-
Investigational Site Number : 3560009
Bengaluru, 560054, India
-
Investigational Site Number : 3560011
Jaipur, 302020, India
-
Investigational Site Number : 3560014
Visakhapatnam, 530040, India
-
Investigational Site Number: 3560013
Pune, 411057, India
Conditions
Explore the condition pages connected to this study.